C12Y 207/11023
[rna-polymerase-subunit] kinase
Official title: [RNA-polymerase-subunit] kinase (2.7.11.23)
C12Y207/11023 ([rna-polymerase-subunit] kinase) appears on 5 US grants and 12 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 12
- Assignees
- 9
- Inventors
- 19
- Latest grant
- 14 Jan 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 2 |
| 2018 | 0 | 0 |
| 2019 | 1 | 2 |
| 2020 | 1 | 2 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- RNA polymerase variants14 Jan 2025US 12,195,778 B2ModernaTX, Inc.
- RNA polymerase variants26 Sep 2023US 11,767,548 B2ModernaTX, Inc.
- RNA polymerase variants20 Jul 2021US 11,066,686 B2ModernaTX, Inc.
- RNA polymerase variants7 Jan 2020US 10,526,629 B2ModernaTX, Inc.
- Method and kits for identifying of CDK9 inhibitors for the treatment of cancer20 Aug 2019US 10,383,873 B2Memorial Sloan Kettering Cancer Center
- Means and methods to target endogenous condensates23 Jul 2026US 2026/0209722 A1Massachusetts Institute of Technology
- Polynucleotide for treatment of neurodegenerative disease, vector, cell, pharmaceutical composition, and screening method11 Sep 2025US 2025/0281642 A1Riken
- Rna polymerase variants19 Jun 2025US 2025/0197908 A1ModernaTX, Inc.
- Rna polymerase variants28 Mar 2024US 2024/0102066 A1ModernaTX, Inc.
- Rna polymerase variants23 Dec 2021US 2021/0395792 A1ModernaTX, Inc.
Most cited
By later US patents
- RNA polymerase variants78US 10,526,629 B2ModernaTX, Inc. · 2020
- Method and kits for identifying of CDK9 inhibitors for the treatment of cancer1US 10,383,873 B2Memorial Sloan Kettering Cancer Center · 2019
- RNA polymerase variants1US 11,066,686 B2ModernaTX, Inc. · 2021
- RNA polymerase variants1US 11,767,548 B2ModernaTX, Inc. · 2023